Announcements Trials
Browse Landscape

Phase

Phase 1 17Phase 1/2 10Phase 2 8Phase EARLY_PHASE1 3Phase NA 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 1041Neoplasms 872Prostatic Neoplasms 506Lung Neoplasms 421Colorectal Neoplasms 357Motor Activity 219Head and Neck Neoplasms 194Uterine Cervical Neoplasms 189Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 114Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Diffuse Intrinsic Pontine Glioma × 1 year × Clear all
NCT03033992 2026-06-02

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

Children's Oncology Group

Phase NA Active not recruiting
80 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡